MicroRNAs as cancer players: potential clinical and biological effects.
about
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinomaAberrantly expressed microRNAs in the context of bladder tumorigenesisMiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cellsMiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progressionTargeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cellsPodocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.MiRNA-mediated control of HLA-G expression and function.High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cellsMicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer.Deep sequencing of RNA from three different extracellular vesicle (EV) subtypes released from the human LIM1863 colon cancer cell line uncovers distinct miRNA-enrichment signatures.TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320aMicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.In-depth characterization of the microRNA transcriptome in a leukemia progression modelLet7b modulates the Wnt/β-catenin pathway in liver cancer cells via downregulated Frizzled4.MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.The effects of alternative splicing on miRNA binding sites in bladder cancer.Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.miR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma.Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis.Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors.MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer.Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells
P2860
Q21134574-BB120AEA-6AD2-4F98-A838-977012116677Q26744152-6010A070-D579-47ED-A238-3D555944FD34Q28271329-AF0310BE-42E1-4D1E-BFF0-6C741E9A4F28Q28393361-1A4ACDC9-C9B2-42BB-B139-150CA788825CQ28476781-015EA1DB-6EF2-4392-9139-A73B99D04E63Q33367473-ABCF2D54-D7F6-4316-A5D2-A03B10C0F713Q34206215-57D6AED2-57E6-4E5B-AF00-976701A9CF88Q34280758-ED6A60B5-B623-477B-A356-9E66038A1CBCQ34299430-B5DB0E45-FD8D-4ABD-A35B-E129ED84F871Q34964080-9839CDBB-6990-48E9-B483-F316680AE64DQ35351470-E9DA7910-9161-4580-86F0-609CA90F7DE5Q35691855-26F177D6-9BC9-43E0-9825-5C2807357541Q36645527-8FE69CE3-B237-4B63-BB3B-27BE599E58B0Q36961241-11C3F50E-2A31-4304-B232-2382516412E7Q38698280-788C21E8-6045-4826-8997-90D759370162Q39283860-C9CF9565-CC46-4A19-B411-BE659694F415Q39494676-1327A53A-784A-4904-B2F8-69B49581B91DQ39613240-E3AE8848-B042-4A83-A66B-E3B84EB0955FQ41950519-E5FB237D-0285-4958-94E4-705FD7463860Q42792442-49C1D4F6-201B-455C-914D-C2AA1DD5A35BQ44415419-05B03AFA-46D9-497A-83F7-6723069EC10FQ47232846-4BECADB4-06C2-416F-A289-B6E543F7FEB8Q47679651-C69C86C1-DF32-4E34-96BE-C7F729C49DF7Q49945184-3E51EF86-96B3-494B-85B6-2A33BA5B92C9Q52725331-2BEA744B-85C2-4028-8406-53323B1FF322Q53265216-9C7A0D8F-67AB-4EA0-BF5C-F0753C07FAC6Q54194714-772CB6D2-A1D2-43AC-8ED1-6029612A9E76Q54295055-5EB44D1E-3C70-4BDD-85B7-9BD47BE37868Q55282272-B27F89CE-9A5C-44C3-B975-9A2E5DC0645AQ58573332-BA5C0EF5-D9A8-4666-9E95-2D595E005617
P2860
MicroRNAs as cancer players: potential clinical and biological effects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MicroRNAs as cancer players: potential clinical and biological effects.
@en
type
label
MicroRNAs as cancer players: potential clinical and biological effects.
@en
prefLabel
MicroRNAs as cancer players: potential clinical and biological effects.
@en
P2093
P356
P1433
P1476
MicroRNAs as cancer players: potential clinical and biological effects.
@en
P2093
Eva Bandres
Jesus Garcia-Foncillas
Natalia Ramirez
Ruth Zarate
P304
P356
10.1089/DNA.2006.0544
P577
2007-05-01T00:00:00Z